Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
32 hedge funds and large institutions have $934K invested in Pernix Therapeutics Holdings, Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 9 closing their positions.
55% more call options, than puts
Call options by funds: $17K | Put options by funds: $11K
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 33 → 32 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
67% less capital invested
Capital invested by funds: $2.87M → $934K (-$1.94M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$50.1K |
| 2 |
Renaissance Technologies
New York
|
+$47.9K |
| 3 |
Barclays
London,
United Kingdom
|
+$43.3K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$38.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$22.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$635K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$177K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$84K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$51K |
| 5 |
VF
Virtu Financial
New York
|
-$27.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
26
Highbridge Capital Management
New York
| – | -$11K | -11,500 | Closed |
|
|
TSS
27
Two Sigma Securities
New York
| – | -$11K | -11,192 | Closed |
|
28
Wells Fargo
San Francisco,
California
| – | -$47 | -75 | -43% |
|
29
Bank of America
Charlotte,
North Carolina
| – | -$37 | -60 | -27% |
|
|
LTFS
30
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$3 | +5 | +56% |
|
31
JP Morgan Chase
New York
| – | +$7 | +11 | New |
|
PTX Hedge Fund Activity: Q4 2018 in Review
32 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q4 2018, worth a combined $934K — down 67% from $2.87M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PTX and 8 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 7 added.
The largest buyer was Geode Capital Management, adding an estimated $50.1K. The largest seller was Deerfield Management, exiting entirely with an estimated $635K sold.
- 32 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q4 2018, down from 33 in Q3 2018.
- Funds reported $934K of Pernix Therapeutics Holdings, Inc. stock for Q4 2018, down 67% quarter-over-quarter.
- 8 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q4 2018 and 9 closed out, a net change of -1 holder.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q4 2018 was Geode Capital Management, an estimated $50.1K added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q4 2018 was Deerfield Management, an estimated $635K sold.
Based on aggregated 13F filings for Q4 2018.